3 ms·
Limiting it to one patent sounds like a great way for companies to just abandon development. Why would you spend hundreds of millions on clinical trials if you
by refurb 4y ago
Limiting it to one patent sounds like a great way for companies to just abandon development.
Why would you spend hundreds of millions on clinical trials if you can't recoup the cost?
- fuzzfactor 4y agoPharma already recoups the cost before the first patent expires. And long ago abandoned development when this criteria is not likely to be met.
- refurb 4y agoYou’re ignoring the drugs that never come to market because costs can’t be recouped. And no, many drugs never recoup costs before the patent runs out. Even the ones that make it to market.